Search

everythinglearnresearchcommunity

for

Search:↓

A woman's hair loss worsened after starting hepatitis C treatment due to immune changes in her hair follicles.

Alopecia areata is caused by immune system issues, and JAK inhibitors might help treat it.

The model showed that immune system guardians and the cytokine interferon-γ are key in alopecia areata progression.

Ginsenoside Rg1 protects mouse skin from UVB damage and helps control inflammation.

COVID-19 can cause various skin issues in children, mostly not severe, with chilblain-like lesions being common, especially in adolescents.

Antioxidants might help with Long Covid by addressing oxidative stress and nutrient imbalances.

Sorafenib may cause hair loss in a way similar to alopecia areata.

Retinol may affect immune responses in people with frequent skin boils.

Alopecia areata is a hair loss disease caused by complex immune reactions, and new targeted treatments show promise.

Activating TLR3 improves the healing and immune properties of periodontal ligament stem cells.

The cause of Frontal fibrosing alopecia, a type of hair loss, is complex, likely involving immune responses and genetics, but is not fully understood.

Frontal fibrosing alopecia shows increased inflammation and JAK-STAT pathway activity without reduced hair proteins.

Specific immune cells cause alopecia areata and blocking certain proteins can prevent it.

Deleting the BRD4 protein in certain skin cells causes hair loss and skin inflammation.

Hair follicle stem cells can help treat ulcerative colitis in mice by releasing beneficial exosomes.

Astilbin can potentially calm overactive immune responses, like in Type 1 Diabetes, by suppressing certain cell activities and reducing inflammation.

Hair cortisol levels peak in the third trimester and decline postpartum.

Understanding the immune-related causes of Alopecia Areata has led to potential treatments like JAK inhibitors.

Rituximab therapy successfully treated a patient's complete body hair loss and was effective for six years.

Nanostructured lipid carriers effectively deliver tofacitinib to hair follicles, reversing hair loss in alopecia areata.

Alopecia areata and vitiligo share immune system dysfunction but differ in specific immune responses and affected areas.

Higher levels of certain DNAs in blood may indicate hair follicle damage in alopecia areata patients.

Blocking the protein CXCL12 with a specific antibody can increase hair growth in common hair loss conditions.

Skin spheroids with both outer and inner layers are key for regrowing skin patterns and hair.

Blocking TYK2 might be a new way to treat hair loss from alopecia areata.

Interferon beta treatment in MS patients can cause skin reactions and increased hair loss.

Some multiple sclerosis treatments may trigger hair loss conditions like alopecia areata.

Booster shots of mRNA vaccines for COVID-19 increased protective antibodies without worsening autoimmune skin conditions in patients.

The research developed methods to test drugs that could protect and restore hair follicle protection in a hair loss condition.

JAK inhibitors help hair growth by boosting beta-catenin activity in hair root cells.